| |
| |
|
| Insider
Information: |
Tang Capital Partners Lp |
| Relationship: |
10% Owner |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
15 |
|
| Direct
Shares |
123,746 |
|
|
Indirect Shares
|
35,438,120 |
|
|
| Direct
Value |
$25,042 |
|
|
|
Indirect Value
|
$71,622,161 |
|
|
| Total
Shares |
35,561,866 |
|
|
| Total
Value |
$71,647,202 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
14
|
1
|
|
Stock
price went up :
|
3
|
0
|
| Stock
price went down : |
11
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
 -4.3%
|
-74.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ardea Biosciences Inc |
RDEA |
10% Owner |
2012-02-01 |
15,089 |
2012-02-01 |
3,800,634 |
Premium* |
|
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
2018-09-12 |
6,941 |
2018-09-12 |
5,844,562 |
Premium* |
|
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
2008-02-15 |
0 |
2008-02-19 |
25,953 |
Premium* |
|
|
Northstar Neuroscience Inc |
NSTR |
10% Owner |
2008-11-18 |
27,000 |
2008-11-18 |
3,706,926 |
Premium* |
|
|
Neose Technologies Inc |
NTEC |
10% Owner |
|
0 |
2008-09-30 |
10,412,306 |
Premium* |
|
|
Molecular Templates, Inc. |
MTEM |
10% Owner |
2008-08-29 |
4,716 |
2008-09-29 |
785,920 |
Premium* |
|
|
Vanda Pharmaceuticals Inc. |
VNDA |
10% Owner |
|
0 |
2010-01-14 |
2,715,852 |
Premium* |
|
|
Aradigm Corp |
ARDM |
10% Owner |
2008-10-21 |
70,000 |
2008-10-21 |
5,877,000 |
Premium* |
|
|
Penwest Pharmaceuticals Co |
PPCO |
10% Owner |
2009-01-09 |
0 |
2010-09-20 |
0 |
Premium* |
|
|
La Jolla Pharmaceutical Co |
LJPC |
|
|
0 |
2014-07-23 |
1,699,067 |
Premium* |
|
|
Cyclacel Pharmaceuticals Inc |
CYCC |
10% Owner |
|
0 |
2017-02-23 |
559,900 |
Premium* |
|
|
Aptevo Therapeutics Inc. |
APVO |
Exit Filing |
2020-11-04 |
0 |
2021-11-23 |
0 |
Premium* |
|
|
Jounce Therapeutics Inc |
JNCE |
10% Owner |
2023-03-13 |
0 |
2023-05-03 |
10,000 |
Premium* |
|
|
Tcr2 Therapeutics Inc. |
TCRR |
10% Owner |
2023-05-03 |
0 |
2023-06-01 |
0 |
Premium* |
|
|
Rain Therapeutics Inc. |
RAIN |
10% Owner |
2023-05-30 |
0 |
2024-01-26 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
176 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RDEA |
Ardea Biosciences Inc |
10% Owner |
– – • |
2010-11-15 |
5 |
GD |
$0.00 |
$0 |
I/I |
225,000 |
67,052 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
10% Owner |
– – • |
2011-01-20 |
4 |
B |
$26.00 |
$5,512,000 |
I/I |
212,000 |
3,307,112 |
1.5 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • • |
2011-06-29 |
4 |
A |
$0.15 |
$7,500,000 |
I/I |
50,000,000 |
60,436,506 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
10% Owner |
– – • |
2012-02-01 |
4 |
B |
$17.00 |
$7,249,990 |
I/I |
426,470 |
3,733,582 |
1.5 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • • |
2012-07-25 |
4 |
A |
$0.53 |
$5,000,000 |
I/I |
9,523,810 |
69,960,316 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
10% Owner |
– – • |
2012-12-19 |
5 |
GD |
$0.00 |
$0 |
I/I |
5,746,716 |
64,213,600 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
10% Owner |
– – • |
2013-11-20 |
4 |
A |
$0.40 |
$7,000,000 |
I/I |
17,500,000 |
81,713,600 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
10% Owner |
– – • |
2014-06-25 |
4 |
B |
$11.75 |
$5,999,997 |
I/I |
510,638 |
4,596,318 |
1.5 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
|
– – • |
2014-07-23 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,699,067 |
|
- |
|
| HRTX |
Heron Therapeutics Inc |
10% Owner |
– – • |
2015-05-29 |
4 |
B |
$19.74 |
$2,274,058 |
I/I |
115,225 |
4,711,543 |
1.5 |
- |
|
| HRTX |
Heron Therapeutics Inc |
10% Owner |
– – • |
2015-06-01 |
4 |
B |
$19.30 |
$45,934 |
I/I |
2,380 |
4,713,923 |
1.5 |
- |
|
| HRTX |
Heron Therapeutics Inc |
10% Owner |
– – • |
2015-06-02 |
4 |
B |
$23.84 |
$772,294 |
I/I |
32,395 |
4,746,318 |
1.5 |
- |
|
| HRTX |
Heron Therapeutics Inc |
10% Owner |
– – • |
2015-06-10 |
4 |
B |
$24.75 |
$2,999,997 |
I/I |
121,212 |
4,867,530 |
1.5 |
- |
|
| HRTX |
Heron Therapeutics Inc |
10% Owner |
– – • |
2016-06-16 |
4 |
D |
$18.47 |
$4,500,012 |
I/I |
(243,639) |
5,873,891 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
10% Owner |
– – • |
2016-06-16 |
4 |
OE |
$3.60 |
$4,500,000 |
I/I |
1,250,000 |
6,117,530 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
10% Owner |
– – • |
2017-01-19 |
4 |
B |
$12.20 |
$29,999,995 |
I/I |
2,459,016 |
8,332,907 |
1.5 |
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
10% Owner |
– – • |
2017-02-23 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
425,700 |
|
- |
|
| CYCC |
Cyclacel Pharmaceuticals ... |
10% Owner |
– – • |
2017-02-23 |
4 |
B |
$4.34 |
$582,079 |
I/I |
134,200 |
559,900 |
1.5 |
- |
|
| HRTX |
Heron Therapeutics Inc |
10% Owner |
– – • |
2018-03-29 |
4 |
B |
$26.00 |
$5,000,008 |
I/I |
192,308 |
8,525,215 |
1.5 |
- |
|
| HRTX |
Heron Therapeutics Inc |
10% Owner |
– – • |
2018-09-12 |
4 |
S |
$35.75 |
$96,346,250 |
I/I |
(2,695,000) |
5,830,215 |
0 |
- |
|
| APVO |
Aptevo Therapeutics Inc. |
10% Owner |
– – • |
2020-11-04 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
323,325 |
|
% |
|
| APVO |
Aptevo Therapeutics Inc. |
10% Owner |
– – • |
2020-11-04 |
4 |
B |
$10.63 |
$9,137,026 |
I/I |
636,675 |
960,000 |
1.5 |
% |
|
| APVO |
Aptevo Therapeutics Inc. |
10% Owner |
– – • |
2020-11-05 |
4 |
B |
$14.22 |
$11,750,307 |
I/I |
625,723 |
1,585,723 |
1.5 |
% |
|
| APVO |
Aptevo Therapeutics Inc. |
10% Owner |
– – • |
2020-11-06 |
4 |
B |
$20.63 |
$3,961,898 |
I/I |
174,277 |
1,760,000 |
1.5 |
% |
|
| APVO |
Aptevo Therapeutics Inc. |
Exit Filing |
– – – |
2021-11-23 |
4 |
S |
$9.60 |
$10,368,236 |
I/I |
(921,336) |
0 |
0 |
% |
|
176 Records found
|
|
Page 6 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
